Ethnic differences in catechol O-methyltransferase pharmacogenetics: Frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals

Pharmacogenetics

Volumn 8, Issue 3, 1998, Pages 195-199

  McLeod, Howard L ^a,e   Syvänen, Ann Christine ^b   Githang'a, Jessie ^c   Indalo, Anne ^c   Ismail, Debbie ^a   Dewar, Kevin ^a   Ulmanen, Ismo ^d   Sludden, Julieann ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d ORION CORPORATION   (Finland)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Catechol O methyltransferase; Ethnic group; Minisequencing; Pharmacogenetics

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; AUTOSOMAL RECESSIVE INHERITANCE; CAUCASIAN; CODON; DRUG INACTIVATION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE SEQUENCE; HUMAN; HUMAN EXPERIMENT; KENYA; MALE; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RACE DIFFERENCE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ALLELES; CATECHOL O-METHYLTRANSFERASE; CODON; ERYTHROCYTES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDIA; KENYA; MALE; MIDDLE AGED; PAKISTAN; SCOTLAND;

EID: 0031777394     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chen C-H, Lee Y-R, Wei F-C, Koong F-J, Hwu H-G, Hsiao K-J. Association study of NIaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 1997; 41:985-987.
2. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 1996; 153:268-270.
3. Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin R et al. Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder. Am J Psych 1997; 154:113-115.
4. Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, Alchalabi A et al. No association between Parkinson's disease and low-activity alleles of catechol-O-methyltransferase. Biochem Biophy Res Communication 1996; 228:780-784.
5. Kalow W. Pharmacoanthropology and the genetics of drug metabolism. In Kalow W, editors. Pharmacogenetics of drug metabolism. New York: Pergamon Press; 1992, pp. 865-877.
6. Kalow W, Bertilsson L. Interethnic factors affecting drug response. Adv Drug Res 1994; 25:1-53.
7. Karayiorgou M, Altemus M, Gake BL, Goldman D, Murphy D, Ott J et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 1997; 94:4572-4575.
8. Klemetsdal B, Straume B, Giverhaug T, Aarbakke J. Low catechol-O-methyltransferase activity in a Saami population. Eur J Clin Pharmacol 1994; 46:231-235.
9. Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, Hoda F et al. High and low activity alleles of catechol-O-methyltransferase gene: ethnic differences and possible association with Parkinson's disease. Neuro Lett 1997; 221:202-204.
10. Lachman HM, Marrow B, Shprintzen R, Veit S, Parsia SS, Faedda G et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velocardio-facial syndrome. Am J Med Genet 1996a; 67:468-472.
11. Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996b; 6:243-250.
12. Li T, Vallada H, Curtis D, Arranz M, Xu K, Cai G et al. Catechol-O-methyltransferase Val 158 Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics 1997; 7:349-353.
13. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I et al. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase - a revised mechanism and description of the thermolabile variant of the enzyme. Biochem 1995; 34:4202-4210.
14. Lundström K, Salminen M, Jalanko A, Savolainen R, Ulmanen I. Cloning and characterization of human placental cathechol-O-methyltransferase cDNA. DNA Cell Biol 1991; 10:206-212.
15. Lundström K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1995; 1251:1-10.
16. McLeod HL, Fang L, Luo X, Scott EP, Evans WE. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exper Ther 1994; 270:26-29.
17. Rivera-Calimlim L, Reilly DK. Difference in erythrocyte catechol-O-methyltransferase activity between orientals and Caucasians: difference in levodopa tolerance. Clin Pharmacol Ther 1984; 35:804-809.
18. Spielman RS, Weinshilboum RM. Genetics of red cell COMT activity: analysis of thermal stability and family data. Am J Genet 1981; 10:279-290.
19. Syvänen A-C, Sajantila A, Lukka M. Identification of individuals by analysis of biallelic DNA-markers using PCR and solid-phase minisequencing. Am J Hum Genet 1993; 52:46-59.
20. Syvänen AC, Tilgmann C, Rinne J, Ulmanen I. Genetic polymorphism of catechol-O-methytlransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian subjects in Finland. Pharmacogenetics 1997; 7:65-71.
21. Weinshilboum RM. Methylation pharmacogenetics: thiopurine methyltransferase as a model system. Xenobiotica 1992; 22:1055-1071.
22. 1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Movement Disorders 1997; 12:426-427.